350 related articles for article (PubMed ID: 25210180)
1. Cholesterol-dependent membrane fusion induced by the gp41 membrane-proximal external region-transmembrane domain connection suggests a mechanism for broad HIV-1 neutralization.
Apellániz B; Rujas E; Carravilla P; Requejo-Isidro J; Huarte N; Domene C; Nieva JL
J Virol; 2014 Nov; 88(22):13367-77. PubMed ID: 25210180
[TBL] [Abstract][Full Text] [Related]
2. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
[TBL] [Abstract][Full Text] [Related]
3. Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions.
Rujas E; Leaman DP; Insausti S; Ortigosa-Pascual L; Zhang L; Zwick MB; Nieva JL
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386285
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.
Chen J; Frey G; Peng H; Rits-Volloch S; Garrity J; Seaman MS; Chen B
J Virol; 2014 Jan; 88(2):1249-58. PubMed ID: 24227838
[TBL] [Abstract][Full Text] [Related]
5. The Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External Region.
Apellániz B; Rujas E; Serrano S; Morante K; Tsumoto K; Caaveiro JM; Jiménez MÁ; Nieva JL
J Biol Chem; 2015 May; 290(21):12999-3015. PubMed ID: 25787074
[TBL] [Abstract][Full Text] [Related]
6. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM
J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol Constrains the Antigenic Configuration of the Membrane-Proximal Neutralizing HIV-1 Epitope.
Torralba J; de la Arada I; Carravilla P; Insausti S; Rujas E; Largo E; Eggeling C; Arrondo JLR; Apellániz B; Nieva JL
ACS Infect Dis; 2020 Aug; 6(8):2155-2168. PubMed ID: 32584020
[TBL] [Abstract][Full Text] [Related]
8. The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.
Huarte N; Lorizate M; Maeso R; Kunert R; Arranz R; Valpuesta JM; Nieva JL
J Virol; 2008 Sep; 82(18):8986-96. PubMed ID: 18596094
[TBL] [Abstract][Full Text] [Related]
9. Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state.
Wang Y; Kaur P; Sun ZJ; Elbahnasawy MA; Hayati Z; Qiao ZS; Bui NN; Chile C; Nasr ML; Wagner G; Wang JH; Song L; Reinherz EL; Kim M
Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22556-22566. PubMed ID: 31624123
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing Antibodies Targeting HIV-1 gp41.
Caillat C; Guilligay D; Sulbaran G; Weissenhorn W
Viruses; 2020 Oct; 12(11):. PubMed ID: 33114242
[TBL] [Abstract][Full Text] [Related]
12. Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.
Kim S; Filsinger Interrante MV; Kim PS
J Virol; 2023 Jan; 97(1):e0164722. PubMed ID: 36541800
[TBL] [Abstract][Full Text] [Related]
13. A new paradigm in molecular recognition? Specific antibody binding to membrane-inserted HIV-1 epitopes.
Nieva JL; Apellaniz B; Huarte N; Lorizate M
J Mol Recognit; 2011; 24(4):642-6. PubMed ID: 21584875
[TBL] [Abstract][Full Text] [Related]
14. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
Zwick MB; Jensen R; Church S; Wang M; Stiegler G; Kunert R; Katinger H; Burton DR
J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352
[TBL] [Abstract][Full Text] [Related]
15. Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies.
Caillat C; Guilligay D; Torralba J; Friedrich N; Nieva JL; Trkola A; Chipot CJ; Dehez FL; Weissenhorn W
Elife; 2021 Apr; 10():. PubMed ID: 33871352
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions.
Buzon V; Natrajan G; Schibli D; Campelo F; Kozlov MM; Weissenhorn W
PLoS Pathog; 2010 May; 6(5):e1000880. PubMed ID: 20463810
[TBL] [Abstract][Full Text] [Related]
17. Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01.
Pinto D; Fenwick C; Caillat C; Silacci C; Guseva S; Dehez F; Chipot C; Barbieri S; Minola A; Jarrossay D; Tomaras GD; Shen X; Riva A; Tarkowski M; Schwartz O; Bruel T; Dufloo J; Seaman MS; Montefiori DC; Lanzavecchia A; Corti D; Pantaleo G; Weissenhorn W
Cell Host Microbe; 2019 Nov; 26(5):623-637.e8. PubMed ID: 31653484
[TBL] [Abstract][Full Text] [Related]
18. HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.
Chakrabarti BK; Pancera M; Phogat S; O'Dell S; McKee K; Guenaga J; Robinson J; Mascola J; Wyatt RT
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):877-87. PubMed ID: 21158699
[TBL] [Abstract][Full Text] [Related]
19. Recognition of membrane-bound fusion-peptide/MPER complexes by the HIV-1 neutralizing 2F5 antibody: implications for anti-2F5 immunogenicity.
Huarte N; Araujo A; Arranz R; Lorizate M; Quendler H; Kunert R; Valpuesta JM; Nieva JL
PLoS One; 2012; 7(12):e52740. PubMed ID: 23285173
[TBL] [Abstract][Full Text] [Related]
20. A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.
Lai RP; Hock M; Radzimanowski J; Tonks P; Hulsik DL; Effantin G; Seilly DJ; Dreja H; Kliche A; Wagner R; Barnett SW; Tumba N; Morris L; LaBranche CC; Montefiori DC; Seaman MS; Heeney JL; Weissenhorn W
J Biol Chem; 2014 Oct; 289(43):29912-26. PubMed ID: 25160627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
